We are constantly seeking advanced, targeted therapies that unlock peak performance and sustained vitality
Patients with specific genetic variants may experience stronger or weaker semaglutide efficacy, or metabolic baseline patterns that amplify prednisone's glucose-raising effect
These include neurocognitive disorders, including Alzheimers and other dementia
The growing global prevalence of type 2 diabetes and obesity has significantly increased demand for GLP-1 receptor agonists such as semaglutide, liraglutide, and tirzepatide, which are known for their ability to manage blood glucose levels, support weight loss, and improve cardiovascular outcomes
We monitor your response and adjust as needed not based on a protocol you follow at home without oversight
Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R